Biomotion Net Interest Income from 2010 to 2026
| SLXN Stock | 1.73 0.04 2.26% |
Net Interest Income | First Reported 2010-12-31 | Previous Quarter -4.4 M | Current Value -4.1 M | Quarterly Volatility 1.8 M |
Check Biomotion Sciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Biomotion Sciences' main balance sheet or income statement drivers, such as Other Operating Expenses of 15.2 M, Total Operating Expenses of 15.2 M or Tax Provision of 17.6 K, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or Days Sales Outstanding of 0.0. Biomotion financial statements analysis is a perfect complement when working with Biomotion Sciences Valuation or Volatility modules.
Biomotion | Net Interest Income | Build AI portfolio with Biomotion Stock |
Evaluating Biomotion Sciences's Net Interest Income across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Biomotion Sciences Ordinary's fundamental strength.
Latest Biomotion Sciences' Net Interest Income Growth Pattern
Below is the plot of the Net Interest Income of Biomotion Sciences Ordinary over the last few years. It is the difference between the revenue generated from a bank's interest-bearing assets and the expenses associated with paying its interest-bearing liabilities. Biomotion Sciences' Net Interest Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Biomotion Sciences' overall financial position and show how it may be relating to other accounts over time.
| Net Interest Income | 10 Years Trend |
|
Net Interest Income |
| Timeline |
Biomotion Net Interest Income Regression Statistics
| Arithmetic Mean | (753,880) | |
| Coefficient Of Variation | (234.30) | |
| Mean Deviation | 1,302,978 | |
| Median | 29,000 | |
| Standard Deviation | 1,766,345 | |
| Sample Variance | 3.1T | |
| Range | 5M | |
| R-Value | (0.65) | |
| Mean Square Error | 1.9T | |
| R-Squared | 0.42 | |
| Significance | 0 | |
| Slope | (227,183) | |
| Total Sum of Squares | 49.9T |
Biomotion Net Interest Income History
About Biomotion Sciences Financial Statements
Biomotion Sciences investors utilize fundamental indicators, such as Net Interest Income, to predict how Biomotion Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Net Interest Income | -4.4 M | -4.1 M |
Pair Trading with Biomotion Sciences
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Biomotion Sciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biomotion Sciences will appreciate offsetting losses from the drop in the long position's value.Moving together with Biomotion Stock
Moving against Biomotion Stock
| 0.7 | IMMP | Immutep Ltd ADR | PairCorr |
| 0.6 | DSGN | Design Therapeutics | PairCorr |
| 0.6 | ENGN | enGene Holdings Common | PairCorr |
| 0.55 | 63E | ONWARD MEDICAL BV | PairCorr |
| 0.5 | KYTX | Kyverna Therapeutics | PairCorr |
The ability to find closely correlated positions to Biomotion Sciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Biomotion Sciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Biomotion Sciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Biomotion Sciences Ordinary to buy it.
The correlation of Biomotion Sciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Biomotion Sciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Biomotion Sciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Biomotion Sciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Biomotion Sciences Correlation against competitors. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Will Biotechnology sector continue expanding? Could Biomotion diversify its offerings? Factors like these will boost the valuation of Biomotion Sciences. If investors know Biomotion will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Biomotion Sciences data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
The market value of Biomotion Sciences is measured differently than its book value, which is the value of Biomotion that is recorded on the company's balance sheet. Investors also form their own opinion of Biomotion Sciences' value that differs from its market value or its book value, called intrinsic value, which is Biomotion Sciences' true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Biomotion Sciences' market value can be influenced by many factors that don't directly affect Biomotion Sciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biomotion Sciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Biomotion Sciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, Biomotion Sciences' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.